Pharma Reviews: IMF Trims India's FY17 Growth Forecast Citing Sluggish Investment Recovery

“In India, economic activity remains buoyant, but the growth forecast for ... Indian pharmaceutical companies are eyeing the opportunity created by ...
Read more: IMF Trims India's FY17 Growth Forecast Citing Sluggish Investment Recovery